Vertex Pharmaceuticals (VRTX) received a significant boost as Health Canada's approval of ALYFTREK marked a vital step in expanding cystic fibrosis treatment options. This approval and other ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2025 financial results on Monday, August 4, 2025 after the financial market ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most ...

The one-month return of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was 1.75%, and its shares lost 5.47% of their value over the last 52 weeks.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.

Trinasolar’s Vertex modules, based on 210mm technology platform, provide high power output, superior efficiency, and long-term reliability. These features lower the levelized cost of electricity (LCOE ...

Vertex Pharma says its much-anticipated non-opioid painkiller, VX-548, clears two phase 3 trials en route to an FDA filing later this year.

Read about Vertex Pharmaceuticals Inc (VRTX:XNAS) stock and today's latest news and financial updates.

Vertex Pharmaceuticals Share Price Live Today:Get the Live stock price of VRTX Inc., and quote, performance, latest news to help you with stock trading and investing.Check out why Vertex ...

View the most recent data and latest information on option chains for Vertex Pharmaceuticals Incorporated Common Stock (VRTX) at Nasdaq.com.

Medically reviewed by Sohaib Imtiaz, MD There is some evidence that garlic may help lower blood pressure. Studies show that garlic supplements or adding fresh garlic to meals may lead to a small ...